Researchers are revisiting old drugs and designing new ones to prevent and treat COVID.
Articles on COVID-19 treatments
Displaying all articles
According to a letter from Biden’s doctor, the president has a runny nose, mild fatigue and a slight cough. The letter also noted that Biden began taking an antiviral drug the morning he tested positive.
The key to supporting science innovation is funding and shaping it at its earliest stages, while innovative ventures are still housed within universities — and even before the ventures are founded.
Just as access to vaccines was vastly more difficult for low-income countries, the same is now true for the virus’ treatments: at potentially great cost to the world.
Imagine if the PM had caught COVID two years ago? We knew so little about COVID with certainty back then, and what we did know was truly frightening. Here’s what’s changed since then.
They’re calling for advice before using bleach or disinfectant. Or they’re calling to ask about side-effects after gargling, spraying or bathing in them. It’s a worry.
Plasma therapy sounded great at the start of the pandemic. Give COVID patients blood plasma from people who had recovered. But the evidence is in. It doesn’t work.
A lot has changed in COVID treatment since the pandemic began. Here are the treatments you can expect — from being diagnosed, to going to hospital, and for those who need to be cared for in ICU.
Medications to treat COVID-19 are in no way a substitute for the vaccine. But under the right circumstances, some show great promise for helping patients.
Top contributors
-
Assistant Professor of Infectious Diseases, University of Virginia
-
PhD candidate, La Trobe University and Unit Head, Nossal Institute for Global Health, The University of Melbourne
-
Clinical Educator, Faculty of Pharmacy, University of Sydney
-
Director, Australian Living Evidence Collaboration; Professor (Research), School of Population Health and Preventive Medicine, Monash University
-
Conjoint Associate Professor in Clinical Pharmacology and Toxicology, St Vincent’s Healthcare Clinical Campus, UNSW
-
Professor of Public Health, La Trobe University
-
Director, Intensive Care Unit, Alfred Health; Professor, Epidemiology and Preventative Medicine, Monash University
-
Van Dusen Professor of Innovation and Entrepreneurship , Simon Fraser University
-
Associate Professor and Research Leader in Virology and Infectious Disease, Griffith University
-
Head of School and Dean of Pharmacy, University of Sydney
-
Senior Lecturer, Sydney Pharmacy School, University of Sydney
-
Associate Professor, Epidemiology, Deakin University
-
Executive Director, National COVID-19 Clinical Evidence Taskforce, and Professor, School of Public Health and Preventive Medicine, Monash University